List of bibliographic references
Number of relevant bibliographic references: 713.
[0-20] [
0 - 20][
0 - 50][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000000 (2009) |
Susan P. Bruce [États-Unis] | Recent Developments in the Treatment of Rheumatoid Arthritis |
| 000008 (2010) |
P. Roll [Allemagne] ; A. Rubbert-Roth [Allemagne] ; H.-P. Tony [Allemagne] | Tocilizumab |
| 000010 (2011) |
Katsuaki Kanbe [Japon] ; Atsushi Nakamura [Japon] ; Yasuo Inoue [Japon] ; Kaori Hobo [Japon] | Osteoprotegerin expression in bone marrow by treatment with tocilizumab in rheumatoid arthritis |
| 000012 (2005) |
Norihiro Nishimoto [Japon] | Clinical studies in patients with Castleman’s disease, Crohn’s disease, and rheumatoid arthritis in Japan |
| 000013 (2013) |
Micha Levi [États-Unis] ; Susan Grange [États-Unis] ; Nicolas Frey [Suisse] | Exposure‐Exposure Relationship of Tocilizumab, an Anti–IL‐6 Receptor Monoclonal Antibody, in a Large Population of Patients With Rheumatoid Arthritis |
| 000015 (2013) |
Jörg Kaufmann [Allemagne] ; Eugen Feist [Allemagne] ; Anne-Eve Roske [Allemagne] ; Wolfgang A. Schmidt [Allemagne] | Monotherapy with tocilizumab or TNF-alpha inhibitors in patients with rheumatoid arthritis: efficacy, treatment satisfaction, and persistence in routine clinical practice |
| 000016 (2009) |
Mao Mao An [République populaire de Chine] ; Zui Zou [République populaire de Chine] ; Hui Shen [République populaire de Chine] ; Jun Dong Zhang [République populaire de Chine] ; Yong Bing Cao [République populaire de Chine] ; Yuan Ying Jiang [République populaire de Chine] | The addition of tocilizumab to DMARD therapy for rheumatoid arthritis: a meta-analysis of randomized controlled trials |
| 000017 (2011) |
Katsuaki Kanbe [Japon] ; Qian Chen [États-Unis] ; Atsushi Nakamura [Japon] ; Kaori Hobo [Japon] | Inhibition of MAP kinase in synovium by treatment with tocilizumab in rheumatoid arthritis |
| 000018 (2009) |
Luciana Marti [Brésil] ; Morton Scheinberg [Brésil] | Anti-interleukin 6: first line in rheumatoid arthritis? |
| 000020 (2011) |
Taras Gout [Royaume-Uni] ; Andrew J. K. Östör [Royaume-Uni] ; Muhammad K. Nisar [Royaume-Uni] | Lower gastrointestinal perforation in rheumatoid arthritis patients treated with conventional DMARDs or tocilizumab: a systematic literature review |
| 000021 (2010) |
Nicolas Frey [Suisse] ; Susan Grange [Suisse] ; Thasia Woodworth [Royaume-Uni] | Population Pharmacokinetic Analysis of Tocilizumab in Patients With Rheumatoid Arthritis |
| 000022 (2011) |
Leonid Gibiansky [États-Unis] ; Nicolas Frey [États-Unis] | Linking interleukin-6 receptor blockade with tocilizumab and its hematological effects using a modeling approach |
| 000024 (2012) |
A. Finet [France] ; M. Amini-Adle [France] ; B. Balme [France] ; F. Colson [France] ; L. Thomas [France] | Nodular progression of lentigo malignant melanoma during a treatment with tocilizumab: cause or coincidence? |
| 000025 (2014) |
Shuji Ohta [Japon] ; Tomomi Tsuru [Japon] ; Kimio Terao [Japon] ; Seiji Mogi [Japon] ; Midori Suzaki [Japon] ; Eisuke Shono [Japon] ; Yoshimasa Ishida [Japon] ; Eriko Tarumi [Japon] ; Masato Imai [Japon] | Mechanism‐based approach using a biomarker response to evaluate tocilizumab subcutaneous injection in patients with rheumatoid arthritis with an inadequate response to synthetic DMARDs (MATSURI study) |
| 000026 (2016) |
Young Ho Lee [Corée du Sud] ; Sang-Cheol Bae [Corée du Sud] | Comparative efficacy and safety of tocilizumab, rituximab, abatacept and tofacitinib in patients with active rheumatoid arthritis that inadequately responds to tumor necrosis factor inhibitors: a Bayesian network meta‐analysis of randomized controlled trials |
| 000032 (2010) |
Daichi Inoue [Japon] ; Hiroshi Arima [Japon] ; Chiharu Kawanami [Japon] ; Yoko Takiuchi [Japon] ; Seiji Nagano [Japon] ; Takaharu Kimura [Japon] ; Sonoko Shimoji [Japon] ; Minako Mori [Japon] ; Sumie Tabata [Japon] ; Soshi Yanagita [Japon] ; Akiko Matsushita [Japon] ; Kenichi Nagai [Japon] ; Yukihiro Imai [Japon] ; Takayuki Takahashi [Japon] | Excellent therapeutic effect of tocilizumab on intestinal amyloid a deposition secondary to active rheumatoid arthritis |
| 000033 (2010) |
Shin-Ya Kawashiri [Japon] ; Atsushi Kawakami [Japon] ; Noriho Sakamoto [Japon] ; Yuji Ishimatsu [Japon] ; Katsumi Eguchi [Japon] | A fatal case of acute exacerbation of interstitial lung disease in a patient with rheumatoid arthritis during treatment with tocilizumab |
| 000034 (2010) |
Masahiro Iwamoto [Japon] ; Sumiko Honma [Japon] ; Yasushi Asano [Japon] ; Seiji Minota [Japon] | Effective and safe administration of tocilizumab to a patient with rheumatoid arthritis on haemodialysis |
| 000035 (2013) |
T. Witte [Allemagne] | Methotrexat als Kombinationspartner bei TNF-Inhibitoren und Tocilizumab |
| 000037 (2012) |
Haider M. Al Attia ; Mohamed Abushawish | Treatment with tocilizumab leads to the disappearance of olecranon rheumatoid nodules |
| 000039 (2011) |
Toshio Tanaka [Japon] ; Keisuke Hagihara [Japon] ; Yoshihito Shima [Japon] ; Masashi Narazaki [Japon] ; Atsushi Ogata [Japon] ; Atsushi Kumanogoh [Japon] | Tocilizumab, a humanized anti‐interleukin‐6 receptor antibody, for the treatment of autoimmune disorders |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "rheumatoid"
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i \
-Sk "rheumatoid" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= TocilizumabV1
|flux= Istex
|étape= Curation
|type= indexItem
|index= AbsEn.i
|clé= rheumatoid
}}
| This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021 |  |
